Clinical Trials in Colorado

Showing 9561-9580 of 18,143 trials

A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors

NCT03261947

The purpose of this study is to confirm the safety and tolerability of TAK-931 in a cohort of Western participants with metastatic solid tumors and to evaluate the anti-tumor activity of TAK-931 in participants with metastatic pancreatic cancer, colorectal cancer (CRC), squamous esophageal cancer (sqEC), and squamous non-small-cell lung cancer (sqNSCLC).

Metastatic Pancreatic CancerColorectal CancerEsophageal Neoplasms+1 more

Millennium Pharmaceuticals, Inc.101 participantsStarted Oct 2017

Denver, Colorado, United States • Sarasota, Florida, United States • Minneapolis, Minnesota, United States +7 more locations

COMPLETEDPhase 253 miles

A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa

NCT04599881

Protocol PTR-01-002 is a 3-part Phase 2, open-label study of PTR-01. While new patients will be enrolled, priority will be given to patients that satisfactorily completed study PTR-01-001.

Recessive Dystrophic Epidermolysis Bullosa

Phoenix Tissue Repair, Inc.6 participantsStarted Oct 2020

Redwood City, California, United States • Aurora, Colorado, United States

A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors

A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa

Find Trials by Condition in Colorado

Pharmacogenetic Prediction of Metoprolol Effectiveness

Insulin Pump to Multiple Daily Injection Transition Clinical Trial

Treatment of Tracheostomy Granulomas

Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 Diabetes

A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

Dose Range Study of CD5789 in Acne Vulgaris

Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects

OptiMesh® for Lumbar Interbody Fusion Trial (OLIF)

Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

Stress Management for Cancer Patients: How Well Does it Work? (C2H-D)

Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)

A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors

A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.

Sertraline Compared With Hypericum Perforatum (St.John's Wort) in Treating Depression

Study of Nolasiban to Increase Pregnancy Rates in Women Undergoing IVF